Potential use of the comet assay in the clinical management of cancer

Declan McKenna; Stephanie McKeown; Valerie J McKelvey-Martin

doi:10.1093/mutage/gem054

Potential use of the comet assay in the clinical management of cancer

Declan McKenna, Stephanie McKeown, Valerie J McKelvey-Martin

Research output: Contribution to journal › Article › peer-review

110 Citations (Scopus)

Abstract

The comet assay has been widely used to measure a range of cellular responses to DNA damage and has found applications in genotoxicity studies, bio-monitoring, ecological testing and in the study of human disease. This review discusses how the comet assay has been applied to the study of DNA damage and repair associated with cancer. The potential of the assay as a tool for predicting an individual's tumour sensitivity to radiation and to various chemotherapeutic drugs is examined, as well as outlining the usefulness of the assay in assessing oxidative stress within tumours. In addition, we review the use of the comet assay in investigations of the DNA-damaging effect of anti-neoplastic drugs and radiation used during cancer therapy. The advantages and limitations of the comet assay in carrying out all these studies are outlined, and the suitability of the comet assay for use in the clinical management of cancer is discussed.

Original language	English
Pages (from-to)	183-190
Journal	Mutagenesis
Volume	23
Issue number	3
DOIs	https://doi.org/10.1093/mutage/gem054
Publication status	Published (in print/issue) - 2008

Keywords

Comet Assay
FISH-Comet
DNA Damage & repair

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/mutage/gem054

Cite this

@article{e9d4bdabc5fd4af5872ac69165e483fd,

title = "Potential use of the comet assay in the clinical management of cancer",

abstract = "The comet assay has been widely used to measure a range of cellular responses to DNA damage and has found applications in genotoxicity studies, bio-monitoring, ecological testing and in the study of human disease. This review discusses how the comet assay has been applied to the study of DNA damage and repair associated with cancer. The potential of the assay as a tool for predicting an individual's tumour sensitivity to radiation and to various chemotherapeutic drugs is examined, as well as outlining the usefulness of the assay in assessing oxidative stress within tumours. In addition, we review the use of the comet assay in investigations of the DNA-damaging effect of anti-neoplastic drugs and radiation used during cancer therapy. The advantages and limitations of the comet assay in carrying out all these studies are outlined, and the suitability of the comet assay for use in the clinical management of cancer is discussed.",

keywords = "Comet Assay, FISH-Comet, DNA Damage & repair",

author = "Declan McKenna and Stephanie McKeown and McKelvey-Martin, {Valerie J}",

year = "2008",

doi = "10.1093/mutage/gem054",

language = "English",

volume = "23",

pages = "183--190",

journal = "Mutagenesis",

issn = "1464-3804",

publisher = "Oxford University Press",

number = "3",

}

TY - JOUR

T1 - Potential use of the comet assay in the clinical management of cancer

AU - McKenna, Declan

AU - McKeown, Stephanie

AU - McKelvey-Martin, Valerie J

PY - 2008

Y1 - 2008

N2 - The comet assay has been widely used to measure a range of cellular responses to DNA damage and has found applications in genotoxicity studies, bio-monitoring, ecological testing and in the study of human disease. This review discusses how the comet assay has been applied to the study of DNA damage and repair associated with cancer. The potential of the assay as a tool for predicting an individual's tumour sensitivity to radiation and to various chemotherapeutic drugs is examined, as well as outlining the usefulness of the assay in assessing oxidative stress within tumours. In addition, we review the use of the comet assay in investigations of the DNA-damaging effect of anti-neoplastic drugs and radiation used during cancer therapy. The advantages and limitations of the comet assay in carrying out all these studies are outlined, and the suitability of the comet assay for use in the clinical management of cancer is discussed.

AB - The comet assay has been widely used to measure a range of cellular responses to DNA damage and has found applications in genotoxicity studies, bio-monitoring, ecological testing and in the study of human disease. This review discusses how the comet assay has been applied to the study of DNA damage and repair associated with cancer. The potential of the assay as a tool for predicting an individual's tumour sensitivity to radiation and to various chemotherapeutic drugs is examined, as well as outlining the usefulness of the assay in assessing oxidative stress within tumours. In addition, we review the use of the comet assay in investigations of the DNA-damaging effect of anti-neoplastic drugs and radiation used during cancer therapy. The advantages and limitations of the comet assay in carrying out all these studies are outlined, and the suitability of the comet assay for use in the clinical management of cancer is discussed.

KW - Comet Assay

KW - FISH-Comet

KW - DNA Damage & repair

U2 - 10.1093/mutage/gem054

DO - 10.1093/mutage/gem054

M3 - Article

SN - 1464-3804

VL - 23

SP - 183

EP - 190

JO - Mutagenesis

JF - Mutagenesis

IS - 3

ER -

Potential use of the comet assay in the clinical management of cancer

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this